AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-84
Results: 1-25/84
DETERMINATION AND VALIDATION OF A PREDICTIVE MODEL FOR CLOSTRIDIUM-DIFFICILE DIARRHEA IN HOSPITALIZED ONCOLOGY PATIENTS
Authors: HORNBUCKLE K CHAK A LAZARUS HM COOPER GS KUTTEH LA GUCALP R CARLISLE PS SPARANO J PARKER P SALATA RA
Citation: K. Hornbuckle et al., DETERMINATION AND VALIDATION OF A PREDICTIVE MODEL FOR CLOSTRIDIUM-DIFFICILE DIARRHEA IN HOSPITALIZED ONCOLOGY PATIENTS, Annals of oncology, 9(3), 1998, pp. 307-311
HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION IN BREAST-CANCER - CURRENT STATUS AND FUTURE-DIRECTIONS
Authors: LAZARUS HM
Citation: Hm. Lazarus, HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION IN BREAST-CANCER - CURRENT STATUS AND FUTURE-DIRECTIONS, Cancer investigation, 16(2), 1998, pp. 102-126
OCCULT TUMOR CONTAMINATION OF HEMATOPOIETIC STEM-CELL PRODUCTS DOES NOT AFFECT CLINICAL OUTCOME OF AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: COOPER BW MOSS TJ ROSS AA YBANEZ J LAZARUS HM
Citation: Bw. Cooper et al., OCCULT TUMOR CONTAMINATION OF HEMATOPOIETIC STEM-CELL PRODUCTS DOES NOT AFFECT CLINICAL OUTCOME OF AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(11), 1998, pp. 3509-3517
AUTOLOGOUS CD34(- EFFECTS OF OVERNIGHT STORAGE ON PERIPHERAL-BLOOD PROGENITOR-CELL ENRICHMENT AND ENGRAFTMENT() CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED LYMPHOMA )
Authors: KOC ON GERSON SL PHILLIPS GL COOPER BW KUTTEH L VANZANT G REECE DE FOX RM SCHUPP JE TAINER N LAZARUS HM
Citation: On. Koc et al., AUTOLOGOUS CD34(- EFFECTS OF OVERNIGHT STORAGE ON PERIPHERAL-BLOOD PROGENITOR-CELL ENRICHMENT AND ENGRAFTMENT() CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED LYMPHOMA ), Bone marrow transplantation, 21(4), 1998, pp. 337-343
LACK OF UTILITY OF THE LYSIS-CENTRIFUGATION BLOOD CULTURE METHOD FOR DETECTION OF FUNGEMIA IN IMMUNOCOMPROMISED CANCER-PATIENTS
Authors: CREGER RJ WEEMAN KE JACOBS MR MORRISSEY A PARKER P FOX RM LAZARUS HM
Citation: Rj. Creger et al., LACK OF UTILITY OF THE LYSIS-CENTRIFUGATION BLOOD CULTURE METHOD FOR DETECTION OF FUNGEMIA IN IMMUNOCOMPROMISED CANCER-PATIENTS, Journal of clinical microbiology, 36(1), 1998, pp. 290-293
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LOW-GRADE LYMPHOMA
Authors: VANBESIEN K SOBOCINSKI K ROWLINGS PA MURPHY SC ARMITAGE JO BISHOP MR CHAEKAL OK GALE RP KLEIN JP LAZARUS HM MCCARTHY PL RAEMAEKERS JMM REIFFERS J PHILLIPS GL SCHATTENBERG AVMB VERDONCK LF VOSE JM HOROWITZ MM
Citation: K. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LOW-GRADE LYMPHOMA, Blood, 92(5), 1998, pp. 1832-1836
HUMAN BONE-MARROW-DERIVED MESENCHYMAL (STROMAL) PROGENITOR CELLS (MPCS) CANNOT BE RECOVERED FROM PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS
Authors: LAZARUS HM HAYNESWORTH SE GERSON SL CAPLAN AI
Citation: Hm. Lazarus et al., HUMAN BONE-MARROW-DERIVED MESENCHYMAL (STROMAL) PROGENITOR CELLS (MPCS) CANNOT BE RECOVERED FROM PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS, Journal of hematotherapy, 6(5), 1997, pp. 447-455
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT FOR BREAST-CANCER IN NORTH-AMERICA
Authors: ANTMAN KH ROWLINGS PA VAUGHAN WP PELZ CJ FAY JW FIELDS KK FREYTES CO GALE RP HILLNER BE HOLLAND HK KENNEDY MJ KLEIN JP LAZARUS HM MCCARTHY PL SAEZ R SPITZER G STADTMAUER EA WILLIAMS SF WOLFF S SOBOCINSKI KA ARMITAGE JO HOROWITZ MM
Citation: Kh. Antman et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT FOR BREAST-CANCER IN NORTH-AMERICA, Journal of clinical oncology, 15(5), 1997, pp. 1870-1879
PREVENTION AND TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE - THE OLDAND THE NEW - A REPORT FROM THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG)
Authors: LAZARUS HM VOGELSANG GB ROWE JM
Citation: Hm. Lazarus et al., PREVENTION AND TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE - THE OLDAND THE NEW - A REPORT FROM THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG), Bone marrow transplantation, 19(6), 1997, pp. 577-600
ERYTHROID BURST-FORMING UNITS (BFU-E) PREDICT HEMATOPOIETIC RECOVERY AFTER PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: COOPER BW MACKAY W GERSON SL LAZARUS HM
Citation: Bw. Cooper et al., ERYTHROID BURST-FORMING UNITS (BFU-E) PREDICT HEMATOPOIETIC RECOVERY AFTER PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER, Bone marrow transplantation, 19(11), 1997, pp. 1089-1094
A PHASE-II TRIAL OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - THE IMPACT OF INVOLVED FIELD RADIATION-THERAPY
Authors: BOYLE T MORR J ROITMAN D WAZER DE LAZARUS HM SCHENKEIN DP
Citation: T. Boyle et al., A PHASE-II TRIAL OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - THE IMPACT OF INVOLVED FIELD RADIATION-THERAPY, Blood, 90(10), 1997, pp. 4547-4547
THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE-IV BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY
Authors: COPELAN E COOPER B KENNEDY MJ MEAGHER R PECORA AL PRETI RA MOREB J WINGARD J HERZIG RM UMIEL T ROSENFELD C LAZARUS HM GLASSCO JE KAHN DG MOSS TJ
Citation: E. Copelan et al., THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE-IV BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY, Blood, 90(10), 1997, pp. 4551-4551
THE PRESENCE OF CLONOGENIC BREAST-CANCER CELLS IN PERIPHERAL-BLOOD STEM-CELL (PBSC) PRODUCTS CORRELATES WITH AN EXTREMELY POOR-PROGNOSIS FOR PATIENTS WITH STAGE-IV DISEASE
Authors: MOSS TJ UMIEL T HERZIG RM MEAGHAR R COOPER B KENNEDY MJ MEAGHER R PETRI RA PERCORA A COPELAN E LAZARUS HM ROSENFELD C
Citation: Tj. Moss et al., THE PRESENCE OF CLONOGENIC BREAST-CANCER CELLS IN PERIPHERAL-BLOOD STEM-CELL (PBSC) PRODUCTS CORRELATES WITH AN EXTREMELY POOR-PROGNOSIS FOR PATIENTS WITH STAGE-IV DISEASE, Blood, 90(10), 1997, pp. 4570-4570
THE PRESENCE OF CLONOGENIC BREAST-CANCER CELLS IN BONE-MARROW (BM) CORRELATES WITH A POOR-PROGNOSIS FOR PATIENTS WITH STAGE-IV DISEASE
Authors: PRILUTSKAYA M UMIEL T HERZIG RM MEAGHAR R COOPER B KENNEDY MJ MEAGHER R PECORA A COPELAN E LAZARUS HM MOS TJ
Citation: M. Prilutskaya et al., THE PRESENCE OF CLONOGENIC BREAST-CANCER CELLS IN BONE-MARROW (BM) CORRELATES WITH A POOR-PROGNOSIS FOR PATIENTS WITH STAGE-IV DISEASE, Blood, 90(10), 1997, pp. 4574-4574
THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE II III BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY/
Authors: UMIEL T COOPER B KENNEDY MJ MEAGHER R PECORA AL ROSENFELD C HERZIG RM COPELAN E LAZARUS HM MOSS TJ
Citation: T. Umiel et al., THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE II III BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY/, Blood, 90(10), 1997, pp. 4586-4586
BREAST-CANCER CONTAMINATION IN PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS ASSOCIATION WITH BONE-MARROW DISEASE AND TYPE OF MOBILIZATION
Authors: PECORA AL LAZARUS HM COOPER B KENNEDY MJ UMIEL T MEAGHER R HERZIG RM COPELAN E PRILUTSKAYA M GLASCO J KAHN DG MOSS TJ
Citation: Al. Pecora et al., BREAST-CANCER CONTAMINATION IN PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS ASSOCIATION WITH BONE-MARROW DISEASE AND TYPE OF MOBILIZATION, Blood, 90(10), 1997, pp. 434-434
CULTURE-EXPANDED AUTOLOGOUS HUMAN MESENCHYMAL STEM-CELLS (MSCS) CIRCULATE IN BLOOD AND RETAIN PROLIFERATIVE CAPACITY FOLLOWING IV INFUSION INTO BREAST-CANCER PATIENTS
Authors: KOC ON DYHOUSE SM GERSON SL HAYNESWORTH SE COOPER BW KUTTEH L CAPLAN A LAZARUS HM
Citation: On. Koc et al., CULTURE-EXPANDED AUTOLOGOUS HUMAN MESENCHYMAL STEM-CELLS (MSCS) CIRCULATE IN BLOOD AND RETAIN PROLIFERATIVE CAPACITY FOLLOWING IV INFUSION INTO BREAST-CANCER PATIENTS, Blood, 90(10), 1997, pp. 1637-1637
THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE II III BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY/
Authors: MOREB J COOPER B HOLLAND K ELLIOT C LAZARUS HM GLUCK S MOSS TJ
Citation: J. Moreb et al., THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE II III BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY/, Blood, 90(10), 1997, pp. 1703-1703
THE RELATIONSHIP BETWEEN THE INCIDENCE OF TUMOR CONTAMINATION AND NUMBER OF PHERESIS FOR STAGE-IV BREAST-CANCER
Authors: KAHN DG PRILUTSKAYA M COOPER B KENNEDY MJ MEAGHER R PECORA AL PETRI RA MOREB J WINGARD J ROSENFELD C HERZIG RM GLASSCO JE UMIEL T COPELAN E LAZARUS HM MOSS TJ
Citation: Dg. Kahn et al., THE RELATIONSHIP BETWEEN THE INCIDENCE OF TUMOR CONTAMINATION AND NUMBER OF PHERESIS FOR STAGE-IV BREAST-CANCER, Blood, 90(10), 1997, pp. 2514-2514
MULTIVARIATE-ANALYSIS OF AUTOTRANSPLANTS FOR PATIENTS WITH AGGRESSIVENON-HODGKIN-LYMPHOMA FAILING PRIMARY INDUCTION THERAPY
Authors: VOSE JM ROWLINGS PA LAZARUS HM PHILLIPS GL ARMITAGE JO HOROWITZ MM
Citation: Jm. Vose et al., MULTIVARIATE-ANALYSIS OF AUTOTRANSPLANTS FOR PATIENTS WITH AGGRESSIVENON-HODGKIN-LYMPHOMA FAILING PRIMARY INDUCTION THERAPY, Blood, 90(10), 1997, pp. 2638-2638
CEFOPERAZONE SULBACTAM VERSUS CEFOPERAZONE PLUS MEZLOCILLIN - EMPIRICTHERAPY FOR FEBRILE, NEUTROPENIC BONE-MARROW TRANSPLANT PATIENTS/
Authors: LAZARUS HM CREGER RJ GUCALP R FOX RM CIOBANU N CARLISLE PS COOPER BW JACOBS MR
Citation: Hm. Lazarus et al., CEFOPERAZONE SULBACTAM VERSUS CEFOPERAZONE PLUS MEZLOCILLIN - EMPIRICTHERAPY FOR FEBRILE, NEUTROPENIC BONE-MARROW TRANSPLANT PATIENTS/, International journal of antimicrobial agents, 7(2), 1996, pp. 85-91
BONE-MARROW TRANSPLANTS FROM HLA-IDENTICAL SIBLINGS IN ADVANCED HODGKINS-DISEASE
Authors: GAJEWSKI JL PHILLIPS GL SOBOCINSKI KA ARMITAGE JO GALE RP CHAMPLIN RE HERZIG RH HURD DD JAGANNATH S KLEIN JP LAZARUS HM MCCARTHY PL PAVLOVSKY S PETERSEN FB ROWLINGS PA RUSSELL JA SILVER SM VOSE JM WIERNIK PH BORTIN MM HOROWITZ MM
Citation: Jl. Gajewski et al., BONE-MARROW TRANSPLANTS FROM HLA-IDENTICAL SIBLINGS IN ADVANCED HODGKINS-DISEASE, Journal of clinical oncology, 14(2), 1996, pp. 572-578
PHASE I II STUDY OF COMBINED GRANULOCYTE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTRATION FOR THE MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS/
Authors: WINTER JN LAZARUS HM RADEMAKER A VILLA M MANGAN C TALLMAN M JAHNKE L GORDON L NEWMAN S BYRD K COOPER BW HORVATH N CRUM E STADTMAUER EA CONKLIN E BAUMAN A MARTIN J GOOLSBY C GERSON SL BENDER J OGORMAN M
Citation: Jn. Winter et al., PHASE I II STUDY OF COMBINED GRANULOCYTE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTRATION FOR THE MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS/, Journal of clinical oncology, 14(1), 1996, pp. 277-286
LONG-TERM FOLLOW-UP OF EDELFOSINE PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA
Authors: VOGLER WR BERDEL WE WINTON EF GORDON DS GELLER RB HEFFNER LT BROCHSTEIN JA BEVERIDGE RA DALTON WS MILLER KB LAZARUS HM
Citation: Wr. Vogler et al., LONG-TERM FOLLOW-UP OF EDELFOSINE PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA, Experimental hematology, 24(9), 1996, pp. 615-615
RANDOMIZED DOUBLE-BLIND EVALUATION OF BOLUS-DOSE VS CONTINUOUS-INFUSION GRANISETRON TO PREVENT VOMITING IN PATIENTS UNDERGOING AUTOTRANSPLANT
Authors: LAZARUS HM CREGER RJ BLUMER JL REED MD
Citation: Hm. Lazarus et al., RANDOMIZED DOUBLE-BLIND EVALUATION OF BOLUS-DOSE VS CONTINUOUS-INFUSION GRANISETRON TO PREVENT VOMITING IN PATIENTS UNDERGOING AUTOTRANSPLANT, Experimental hematology, 24(9), 1996, pp. 621-621
Risultati: 1-25 | 26-50 | 51-75 | 76-84